AB
RPRX icon

Amalgamated Bank’s Royalty Pharma RPRX Stock Holding History

Amalgamated Bank’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Sell
20,292
-16,477
-45% -$858K 0.01% 1050
2026
Q1 		$1.76M Buy
36,769
+15,062
+69% +$660K 0.01% 862
2025
Q4 		$839K Buy
21,707
+386
+2% +$14.7K 0.01% 1141
2025
Q3 		$752K Sell
21,321
-979
-4% -$35.4K 0.01% 1166
2025
Q2 		$803K Buy
22,300
+1,877
+9% +$62.2K 0.01% 1124
2025
Q1 		$636K Buy
20,423
+866
+4% +$27.4K 0.01% 1168
2024
Q4 		$499K Sell
19,557
-912
-4% -$24.2K ﹤0.01% 1298
2024
Q3 		$579K Sell
20,469
-48,057
-70% -$1.33M ﹤0.01% 1249
2024
Q2 		$1.81M Buy
68,526
+47,632
+228% +$1.32M 0.02% 866
2024
Q1 		$635K Sell
20,894
-11,183
-35% -$330K 0.01% 1222
2023
Q4 		$901K Sell
32,077
-3,688
-10% -$101K 0.01% 1214
2023
Q3 		$971K Sell
35,765
-330
-0.9% -$9.8K 0.01% 1129
2023
Q2 		$1.11M Sell
36,095
-3,463
-9% -$117K 0.01% 1096
2023
Q1 		$1.43M Buy
39,558
+2,251
+6% +$83.5K 0.01% 990
2022
Q4 		$1.47M Buy
37,307
+561
+2% +$23.4K 0.01% 1007
2022
Q3 		$1.48M Sell
36,746
-2,506
-6% -$107K 0.01% 960
2022
Q2 		$1.65M Buy
39,252
+4,399
+13% +$180K 0.02% 939
2022
Q1 		$1.36M Buy
+34,853
New +$1.37M 0.01% 1085

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amalgamated Bank's RPRX Position: Q2 2026 in Review

Amalgamated Bank reduced its Royalty Pharma (RPRX) stake by 45% in Q2 2026, selling an estimated $858K and leaving 20,292 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #1050.

Amalgamated Bank first reported a position in RPRX in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.81M in Q2 2024. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Amalgamated Bank held 20,292 shares of Royalty Pharma worth $1.14M as of Q2 2026.
  • Amalgamated Bank sold 16,477 Royalty Pharma shares in Q2 2026, an estimated $858K.
  • Royalty Pharma made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1050 holding.
  • Amalgamated Bank first reported a position in Royalty Pharma in Q1 2022 and has held it in 18 quarters since.
  • Amalgamated Bank's Royalty Pharma position peaked at $1.81M in Q2 2024.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.